10x Genomics Inc.
(TXG)
undefined
undefined%
At close: undefined
16.01
0.50%
After-hours Jan 06, 2025, 05:19 PM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| PE Ratio | -25.7 | -24.99 | -282.32 | -26.39 | -95.31 | -6.28 | -32.58 |
| PS Ratio | 10.60 | 8.03 | 33.51 | 47.93 | 12.11 | 4.83 | 8.60 |
| PB Ratio | 8.85 | 5.15 | 20.11 | 19.38 | 7.09 | -3.21 | -5.43 |
| P/FCF Ratio | -101.3 | -25.1 | -134.02 | -55.89 | -365.92 | -8.5 | -42.29 |
| P/OCF Ratio | -431.44 | -123.46 | -769.07 | -65.73 | 86.02 | -9.25 | -57.13 |
| OCF/S Ratio | -0.02 | -0.07 | -0.04 | -0.73 | 0.14 | -0.52 | -0.15 |
| Debt / Equity Ratio | n/a | 0.12 | 0.10 | 0.09 | 0.07 | -0.13 | -0.09 |
| Quick Ratio | 4.11 | 4.23 | 6.23 | 6.30 | 7.38 | 3.02 | 2.86 |
| Current Ratio | 4.69 | 4.85 | 6.77 | 6.56 | 7.63 | 3.28 | 3.08 |
| Asset Turnover | 0.64 | 0.50 | 0.48 | 0.32 | 0.41 | 1.18 | 0.94 |
| Interest Coverage | -5.91K | -352.82 | -61.1 | -50.73 | -9.44 | -45.98 | -22.66 |
| Return on Equity (ROE) | -0.34 | -0.21 | -0.07 | -0.73 | -0.07 | 0.51 | 0.17 |
| Return on Assets (ROA) | -0.26 | -0.16 | -0.06 | -0.58 | -0.05 | -0.9 | -0.25 |
| Return on Capital (ROIC) | -0.23 | -0.19 | -0.06 | -0.11 | -0.05 | -1.2 | -0.34 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 66.15% | 76.69% | 84.89% | 80.44% | 75.18% | 80.41% | 85.14% |
| Net Profit Margin | -41.23% | -32.15% | -11.87% | -181.61% | -12.71% | -76.88% | -26.39% |
| Pretax Profit Margin | -40.21% | -31.36% | -10.95% | -178.85% | -12.62% | -76.82% | -26.36% |
| Operating Profit Margin | -31.51% | -32.52% | -10.79% | -28.55% | -11.82% | -75.7% | -25.85% |
| FCF Margin | -10.46% | -32% | -25.01% | -85.76% | -3.31% | -56.81% | -20.33% |
| EBITDA Margin | -33.15% | -24.88% | -5.01% | -171.92% | -8.49% | -72.5% | -19.17% |